Secreted WNT antagonists as tumor suppressors: Pro and con

Frontiers in Bioscience

Volumn 11, Issue SUPPL. 1, 2006, Pages 2093-2105

  Rubin, Jeffrey S ^a   Barshishat Kupper, Michal ^a   Feroze Merzoug, Farhana ^a   Xi, Zong Fang ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Dickkopf; Review; sFRP; Tumor Suppressor; WIF 1; Wnt

Indexed keywords

EID: 33744722770     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1952     Document Type: Review

References (113)

1. He, X.: A Wnt-Wnt situation. Dev Cell, 4, 791-7 (2003)
2. Ilyas, M.: Wnt signalling and the mechanistic basis of tumour development. J Pathol, 205, 130-44 (2005)
3. Giles, R. H., J. H. van Es & H. Clevers: Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta, 1653, 1-24 (2003)
4. Rowan, A. J., H. Lamlum, M. Ilyas, J. Wheeler, J. Sträub, A. Papadopoulou, D. Bicknell, W. F. Bodmer & I. P. Tomlinson: APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits". Proc Natl Acad Sci U S A, 97, 3352-7 (2000)
5. Reifenberger, J., C. B. Knobbe, M. Wolter, B. Blaschke, K. W. Schulte, T. Pietsch, T. Ruzicka & G. Reifenberger: Molecular genetic analysis of malignant melanomas for aberrations of the WNT signaling pathway genes CTNNB1, APC, ICAT and BTRC. M J Cancer, 100, 549-56 (2002)
6. Huang, H., B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues & H. Ohgaki: APC mutations in sporadic medulloblastomas. Am J Pathol, 156, 433-7 (2000)
7. Satoh, S., Y. Daigo, Y. Furukawa, T. Kato, N. Miwa, T. Nishiwaki, T. Kawasoe, H. Ishiguro, M. Fujita, T. Tokino, Y. Sasaki, S. Imaoka, M. Murata, T. Shimano, Y. Yamaoka & Y. Nakamura: AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet, 24, 245-50 (2000)
8. Taniguchi, K., L. R. Roberts, I. N. Aderca, X. Dong, C. Qian, L. M. Murphy, D. M. Nagorney, L. J. Burgart, P. C. Roche, D. I. Smith, J. A. Ross & W. Liu: Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene, 21, 4863-71 (2002)
9. Dahmen, R. P., A. Koch, D. Denkhaus, J. C. Tonn, N. Sorensen, F. Berthold, J. Behrens, W. Birchmeier, O. D. Wiestier & T. Pietsch: Deletions of AXIN1, a component of the WNT/wingless pathway, in sporadic medulloblastomas. Cancer Res, 61, 7039-43 (2001)
10. Yokota, N., S. Nishizawa, S. Ohta, H. Date, H. Sugimura, H. Namba & M. Maekawa: Role of Wnt pathway in medulloblastoma oncogenesis. Int J Cancer, 101, 198-201 (2002)
11. Vincan, E.: Frizzled/WNT signalling: the insidious promoter of tumour growth and progression. Front Biosci, 9, 1023-34 (2004)
12. Veeman, M. T., J. D. Axelrod & R. T. Moon: A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell, 5, 367-77 (2003)
13. Kühl, M.: The WNT/calcium pathway: biochemical mediators, tools and future requirements. Front Biosci, 9, 967-74 (2004)
14. Nateri, A. S., B. Spencer-Dene & A. Behrens: Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature, 437, 281-5 (2005)
15. Weeraratna, A. T., Y. Jiang, G. Hostetter, K. Rosenblatt, P. Duray, M. Bittner & J. M. Trent: Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell, 1, 279-88 (2002)
16. Qiang, Y. W., K. Walsh, L. Yao, N. Kedei, P. M. Blumberg, J. S. Rubin, J. Shaughnessy, Jr. & S. Rudikoff: Wnts induce migration and invasion of myeloma plasma cells. Blood, 106, 1786-93 (2005)
17. Olson, D. J., D. M. Gibo, G. Saggers, W. Debinski & R. Kumar: Reversion of uroepithelial cell tumorigenesis by the ectopic expression of human wnt-5a. Cell Growth Differ, 8, 417-23 (1997)
18. Jonsson, M., J. Dejmek, P. O. Bendahl & T. Andersson: Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas. Cancer Res, 62, 409-16 (2002)
19. Kremenevskaja, N., R. von Wasielewski, A. S. Rao, C. Schofl, T. Andersson & G. Brabant: Wnt-5a has tumor suppressor activity in thyroid carcinoma. Oncogene, 24, 2144-54 (2005)
20. Kühl, M., K. Geis, L. C. Sheldahl, T. Pukrop, R. T. Moon & D. Wedlich: Antagonistic regulation of convergent extension movements in Xenopus by Wnt/beta-catenin and Wnt/Ca2+ signaling. Mech Dev, 106, 61-76 (2001)
21. Ishitani, T., S. Kishida, J. Hyodo-Miura, N. Ueno, J. Yasuda, M. Waterman, H. Shibuya, R. T. Moon, J. Ninomiya-Tsuji & K. Matsumoto: The TAK1-NLK mitogen-activated protein kinase cascade functions in the Wnt-5a/Ca (2+) pathway to antagonize Wnt/beta-catenin signaling. MoL Cell Biol, 23, 131-9 (2003)
22. Topol, L., X. Jiang, H. Choi, L. Garrett-Beal, P. J. Carolan & Y. Yang: Wnt-5a inhibits the canonical Wnt pathway by promoting GSK-3-independent beta-catenin degradation. J Cell Biol, 162, 899-908 (2003)
23. Rattner, A., J. C. Hsieh, P. M. Smallwood, D. J. Gilbert, N. G. Copeland, N. A. Jenkins & J. Nathans: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A, 94, 2859-63 (1997)
24. Lin, K., S. Wang, M. A. Julius, J. Kitajewski, M. Moos, Jr. & F. P. Luyten: The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A, 94, 11196-200 (1997)
25. Jones, S. E. & C. Jomary: Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays, 24, 811-20 (2002)
26. Bányai, L. & L. Patthy: The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci, 8, 1636-42 (1999)
27. Üren, A., F. Reichsman, V. Anest, W. G. Taylor, K. Muraiso, D. P. Bottaro, S. Cumberledge & J. S. Rubin: Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem, 275, 4374-82 (2000)
28. Chong, J. M., A. Üren, J. S. Rubin & D. W. Speicher: Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules. J Biol Chem, 277, 5134-44 (2002)
29. Leimeister, C., A. Bach & M. Gessler: Developmental expression patterns of mouse sFRP genes encoding members of the secreted frizzled related protein family. Mech Dev, 75, 29-42 (1998)
30. Hsieh, J. C., L. Kodjabachian, M. L. Rebbert, A. Rattner, P. M. Smallwood, C. H. Samos, R. Nusse, I. B. Dawid & J. Nathans: A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature, 398, 431-6 (1999)
31. He, X.: Wnt signaling went derailed again: a new track via the LIN-18 receptor? Cell, 118, 668-70 (2004)
32. Gorfinkiel, N., J. Sierra, A. Callejo, C. Ibanez & I. Guerrero: The Drosophila ortholog of the human Wnt inhibitor factor Shifted controls the diffusion of lipid-modified Hedgehog. Dev Cell, 8, 241-53 (2005)
33. Glise, B., C. A. Miller, M. Crozatier, M. A. Halbisen, S. Wise, D. J. Olson, A. Vincent & S. S. Blair: Shifted, the Drosophila ortholog of Wnt inhibitory factor-1, controls the distribution and movement of Hedgehog. Dev Cell, 8, 255-66 (2005)
34. Piccolo, S., E. Agius, L. Leyns, S. Bhattacharyya, H. Grunz, T. Bouwmeester & E. M. De Robertis: The head inducer Cerberus is a multifunctional antagonist of Nodal, BMP and Wnt signals. Nature, 397, 707-10 (1999)
35. Kawano, Y. & R. Kypta: Secreted antagonists of the Wnt signalling pathway. J Cell Sci, 116, 2627-34 (2003)
36. Bell, E., I. Munoz-Sanjuan, C. R. Altmann, A. Vonica & A. H. Brivanlou: Cell fate specification and competence by Coco, a maternal BMP, TGFbeta and Wnt inhibitor. Development, 130, 1381-9 (2003)
37. Mao, B., W. Wu, Y. Li, D. Hoppe, P. Stannek, A. Glinka & C. Niehrs: LDL-receptor-related protein 6 is a receptor for Dickkopf proteins. Nature, 411, 321-5 (2001)
38. Semenov, M. V., K. Tamai, B. K. Brott, M. Kühl, S. Sokol & X. He: Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6. Curr Biol, 11, 951-61 (2001)
39. Bafico, A., G. Liu, A. Yaniv, A. Gazit & S. A. Aaronson: Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol, 3, 683-6 (2001)
40. Glinka, A., W. Wu, H. Delius, A. P. Monaghan, C. Blumenstock & C. Niehrs: Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature, 391, 357-62 (1998)
41. Krupnik, V. E., J. D. Sharp, C. Jiang, K. Robison, T. W. Chickering, L. Amaravadi, D. E. Brown, D. Guyot, G. Mays, K. Leiby, B. Chang, T. Duong, A. D. Goodearl, D. P. Gearing, S. Y. Sokol & S. A. McCarthy: Functional and structural diversity of the human Dickkopf gene family. Gene, 238, 301-13 (1999)
42. Brott, B. K. & S. Y. Sokol: Regulation of Wnt/LRP signaling by distinct domains of Dickkopf proteins. Mol Cell Biol, 22, 6100-10 (2002)
43. Mao, B. & C. Niehrs: Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene, 302, 179-83 (2003)
44. Caricasole, A., T. Ferraro, L. Iacovelli, E. Barletta, A. Caruso, D. Melchiorri, G. C. Terstappen & F. Nicoletti: Functional characterization of WNT7A signaling in PC12 cells: interaction with A FZD5 × LRP6 receptor complex and modulation by Dickkopf proteins. J Biol Chem, 278, 37024-31 (2003)
45. Hoang, B. H., T. Kubo, J. H. Healey, R. Yang, S. S. Nathan, E. A. KoIb, B. Mazza, P. A. Meyers & R. Gorlick: Dickkopf 3 inhibits invasion and motility of Saos-2 osteosarcoma cells by modulating the Wnt-beta-catenin pathway. Cancer Res, 64, 2734-9 (2004)
46. Mao, B., W. Wu, G. Davidson, J. Marhold, M. Li, B. M. Mechler, H. Delius, D. Hoppe, P. Stannek, C. Walter, A. Glinka & C. Niehrs: Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature, 417, 664-7 (2002)
47. Wu, W., A. Glinka, H. Delius & C. Niehrs: Mutual antagonism between dickkopfl and dickkopG regulates Wnt/Beta-catenin signalling. Curr Biol, 10, 1611-4 (2000)
48. Itasaki, N., C. M. Jones, S. Mercurio, A. Rowe, P. M. Domingos, J. C. Smith & R. Krumlauf: Wise, a context-dependent activator and inhibitor of Wnt signalling. Development, 130, 4295-305 (2003)
49. Li, X., Y. Zhang, H. Kang, W. Liu, P. Liu, J. Zhang, S. E. Harris & D. Wu: Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J Biol Chem, 280, 19883-7 (2005)
50. Semenov, M., K. Tamai & X. He: SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. J Biol Chem, 280, 26770-5 (2005)
51. Kusu, N., J. Laurikkala, M. Imanishi, H. Usui, M. Konishi, A. Miyake, I. Thesleff & N. Itoh: Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J Biol Chem, 278, 24113-7 (2003)
52. Mercurio, S., B. Latinkic, N. Itasaki, R. Krumlauf & J. C. Smith: Connective-tissue growth factor modulates WNT signalling and interacts with the WNT receptor complex. Development, 131, 2137-47 (2004)
53. Lau, L. F. & S. C. Lam: The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res, 248, 44-57 (1999)
54. Rhee, C. S., M. Sen, D. Lu, C. Wu, L. Leoni, J. Rubin, M. Corr & D. A. Carson: Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas. Oncogene, 21, 6598-605 (2002)
55. Bafico, A., G. Liu, L. Goldin, V. Harris & S. A. Aaronson: An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell, 6, 497-506 (2004)
56. Suzuki, H., D. N. Watkins, K. W. Jair, K. E. Schuebel, S. D. Markowitz, W. D. Chen, T. P. Pretlow, B. Yang, Y. Akiyama, M. Van Engeland, M. Toyota, T. Tokino, Y. Hinoda, K. Imai, J. G. Herman & S. B. Baylin: Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet, 36, 417-22 (2004)
57. Finch, P. W., X. He, M. J. Kelley, A. Üren, R. P. Schaudies, N. C. Popescu, S. Rudikoff, S. A. Aaronson, H. E. Varmus & J. S. Rubin: Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A, 94, 6770-5 (1997)
58. Leach, R. J., S. S. Banga, K. Ben-Othame, S. Chughtai, R. Clarke, S. P. Daiger, J. Kolehmainen, S. Kumar, M. Kuo, J. Macoska, N. Mada, S. L. Naylor, M. Nunes, P. O'Connell, M. J. Pebusque, V. Pekkel, C. J. Porter, C. T. Simons, M. M. Sohocki, J. Trapman, D. Wells, C. Westbrook & S. Wood: Report of the Third International Workshop on Human Chromosome 8 Mapping. San Antonio, Texas, October 25-27, 1996. Cytogenet Cell Genet, 75, 71-84 (1996)
59. Leyns, L., T. Bouwmeester, S. H. Kim, S. Piccolo & E. M. De Robertis: Frzb-1 is a secreted antagonist of Wnt signaling expressed in the Spemann organizer. Cell, 88, 747-56 (1997)
60. Melkonyan, H. S., W. C. Chang, J. P. Shapiro, M. Mahadevappa, P. A. Fitzpatrick, M. C. Kiefer, L. D. Tomei & S. R. Umansky: SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A, 94, 13636-41 (1997)
61. Zhou, Z., J. Wang, X. Han, J. Zhou & S. Linder: Up-regulation of human secreted frizzled homolog in apoptosis and its down-regulation in breast tumors. Int J Cancer, 78, 95-9 (1998)
62. Ugolini, F., J. Adelaide, E. Charafe-Jauffret, C. Nguyen, J. Jacquemier, B. Jordan, D. Birnbaum & M. J. Pebusque: Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes. Oncogene, 18, 1903-10 (1999)
63. Ugolini, F., E. Charafe-Jauffret, V. J. Bardou, J. Geneix, J. Adelaide, F. Labat-Moleur, F. Penault-Llorca, M. Longy, J. Jacquemier, D. Birnbaum & M. J. Pebusque: WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type. Oncogene, 20, 5810-7 (2001)
64. Klopocki, E., G. Kristiansen, P. J. Wild, I. Klaman, E. Castanos-Velez, G. Singer, R. Stohr, R. Simon, G. Sauter, H. Leibiger, L. Essers, B. Weber, K. Hermann, A. Rosenthal, A. Hartmann & E. Dahl: Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. Int J Oncol, 25, 641-9 (2004)
65. Armes, J. E., F. Hammet, M. de Silva, J. Ciciulla, S. J. Ramus, W. K. Soo, A. Mahoney, N. Yarovaya, M. A. Henderson, K. Gish, A. M. Hutchins, G. R. Price & D. J. Venter: Candidate tumor-suppressor genes on chromosome arm 8p in early-onset and high-grade breast cancers. Oncogene, 23, 5697-702 (2004)
66. To, K. F., M. W. Chan, W. K. Leung, J. Yu, J. H. Tong, T. L. Lee, F. K. Chan & J. J. Sung: Alterations of frizzled (FzE3) and secreted frizzled related protein (hsFRP) expression in gastric cancer. Life Sci, 70, 483-9 (2001)
67. Ko, J., K. S. Ryu, Y. H. Lee, D. S. Na, Y. S. Kim, Y. M. Oh, I. S. Kim & J. W. Kim: Human secreted frizzled-related protein is down-regulated and induces apoptosis in human cervical cancer. Exp Cell Res, 280, 280-7 (2002)
68. Suzuki, H., E. Gabrielson, W. Chen, R. Anbazhagan, M. van Engeland, M. P. Weijenberg, J. G. Herman & S. B. Baylin: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet, 31, 141-9 (2002)
69. Herman, J. G. & S. B. Baylin: Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med, 349, 2042-54 (2003)
70. Caldwell, G. M., C. Jones, K. Gensberg, S. Jan, R. G. Hardy, P. Byrd, S. Chughtai, Y. Wallis, G. M. Matthews & D. G. Morton: The Wnt antagonist sFRP1 in colorectal tumorigenesis. Cancer Res, 64, 883-8 (2004)
71. Stoehr, R., C. Wissmann, H. Suzuki, R. Knuechel, R. C. Krieg, E. Klopocki, E. Dahl, P. Wild, H. Blaszyk, G. Sauter, R. Simon, R. Schmitt, D. Zaak, F. Hofstaedter, A. Rosenthal, S. B. Baylin, C. Pilarsky & A. Hartmann: Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Lab Invest, 84, 465-78 (2004)
72. Takada, T., Y. Yagi, T. Maekita, M. Imura, S. Nakagawa, S. W. Tsao, K. Miyamoto, O. Yoshino, T. Yasugi, Y. Taketani & T. Ushijima: Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci, 95, 741-4 (2004)
73. Fukui, T., M. Kondo, G. Ito, O. Maeda, N. Sato, H. Yoshioka, K. Yokoi, Y. Ueda, K. Shimokata & Y. Sekido: Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer. Oncogene, 24, 6323-7 (2005)
74. Zou, H., J. R. Molina, J. J. Harrington, N. K. Osborn, K. K. Klatt, Y. Romero, L. J. Burgart & D. A. Ahlquist: Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus. Int J Cancer, 116, 584-91 (2005)
75. Lee, A. Y., B. He, L. You, S. Dadfarmay, Z. Xu, J. Mazieres, I. Mikami, F. McCormick & D. M. Jablons: Expression of the secreted frizzled-related protein gene family is downregulated in human mesothelioma. Oncogene, 23, 6672-6 (2004)
76. Wissmann, C., P. J. Wild, S. Kaiser, S. Roepcke, R. Stoehr, M. Woenckhaus, G. Kristiansen, J. C. Hsieh, F. Hofstaedter, A. Hartmann, R. Knuechel, A. Rosenthal & C. Pilarsky: WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. J Pathol, 201, 204-12 (2003)
77. Mazieres, J., B. He, L. You, Z. Xu, A. Y. Lee, I. Mikami, N. Reguart, R. Rosell, F. McCormick & D. M. Jablons: Wnt inhibitory factor-1 is silenced by promoter hypermethylation in human lung cancer. Cancer Res, 64, 4717-20 (2004)
78. Wang, J., J. Shou & X. Chen: Dickkopf-1, an inhibitor of the Wnt signaling pathway, is induced by p53. Oncogene, 19, 1843-8 (2000)
79. Shou, J., F. Ali-Osman, A. S. Multani, S. Pathak, P. Fedi & K. S. Srivenugopal: Human Dkk-1, a gene encoding a Wnt antagonist, responds to DNA damage and its overexpression sensitizes brain tumor cells to apoptosis following alkylation damage of DNA. Oncogene, 21, 878-89 (2002)
80. Grotewold, L. & U. Ruther: The Wnt antagonist Dickkopf-1 is regulated by Bmp signaling and c-Jun and modulates programmed cell death. Embo J, 21, 966-75 (2002)
81. Lee, A. Y., B. He, L. You, Z. Xu, J. Mazieres, N. Reguart, I. Mikami, S. Batra & D. M. Jablons: Dickkopf-1 antagonizes Wnt signaling independent of beta-catenin in human mesothelioma. Biochem Biophys Res Commun, 323, 1246-50 (2004)
82. Mikheev, A. M., S. A. Mikheeva, B. Liu, P. Cohen & H. Zarbl: A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation. Carcinogenesis, 25, 47-59 (2004)
83. Gonzalez-Sancho, J. M., O. Aguilera, J. M. Garcia, N. Pendas-Franco, C. Pena, S. Cal, A. Garcia de Herreros, F. Bonilla & A. Munoz: The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. Oncogene, 24, 1098-103 (2005)
84. Tsuji, T., M. Miyazaki, M. Sakaguchi, Y. Inoue & M. Namba: A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun, 268, 20-4 (2000)
85. Tsuji, T., I. Nozaki, M. Miyazaki, M. Sakaguchi, H. Pu, Y. Hamazaki, O. Iijima & M. Namba: Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun, 289, 257-63 (2001)
86. Kobayashi, K., M. Ouchida, T. Tsuji, H. Hanafusa, M. Miyazaki, M. Namba, N. Shimizu & K. Shimizu: Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene, 282, 151-8 (2002)
87. Kurose, K., M. Sakaguchi, Y. Nasu, S. Ebara, H. Kaku, R. Kariyama, Y. Arao, M. Miyazaki, T. Tsushima, M. Namba, H. Kumon & N. H. Huh: Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol, 171, 1314-8 (2004)
88. Hsieh, S. Y., P. S. Hsieh, C. T. Chiu & W. Y. Chen: Dickkopf-3/REIC functions as a suppressor gene of tumor growth. Oncogene, 23, 9183-9 (2004)
89. Roth, W., C. Wild-Bode, M. Platten, C. Grimmel, H. S. Melkonyan, J. Dichgans & M. Weller: Secreted Frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene, 19, 4210-20 (2000)
90. Lee, J. L., C. J. Chang, S. Y. Wu, D. R. Sargan & C. T. Lin: Secreted frizzled-related protein 2 (SFRP2) is highly expressed in canine mammary gland tumors but not in normal mammary glands. Breast Cancer Res Treat, 84, 139-49 (2004)
91. Lee, J. L., C. T. Lin, L. L. Chueh & C. J. Chang: Autocrine/paracrine secreted Frizzled-related protein 2 induces cellular resistance to apoptosis: a possible mechanism of mammary tumorigenesis. J Biol Chem, 279, 14602-9 (2004)
92. Fukuhara, K., M. Kariya, M. Kita, H. Shime, T. Kanamori, C. Kosaka, A. Orii, J. Fujita & S. Fujii: Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab, 87, 1729-36 (2002)
93. Han, X. & S. Amar: Secreted frizzled-related protein 1 (SFRPl) protects fibroblasts from ceramide-induced apoptosis. J Biol Chem, 279, 2832-40 (2004)
94. Joesting, M. S., S. Perrin, B. Elenbaas, S. E. Fawell, J. S. Rubin, O. E. Franco, S. W. Hayward, G. R. Cunha & P. C. Marker: Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer. Cancer Research, 65, 10423-30 (2005)
95. Abu-Jawdeh, G., N. Cornelia, Y. Tomita, L. F. Brown, K. Tognazzi, S. Y. Sokol & O. Kocher: Differential expression of frpHE: a novel human stromal protein of the secreted frizzled gene family, during the endometrial cycle and malignancy. Lab Invest, 79, 439-47 (1999)
96. Wong, S. C., S. F. Lo, K. C. Lee, J. W. Yam, J. K. Chan & W. L. Wendy Hsiao: Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours. J Pathol, 196, 145-53 (2002)
97. Horvath, L. G., S. M. Henshall, J. G. Kench, D. N. Saunders, C. S. Lee, D. Golovsky, P. C. Brenner, G. F. O'Neill, R. Kooner, P. D. Stricker, J. J. Grygiel & R. L. Sutherland: Membranous expression of secreted frizzled-related protein 4 predicts for good prognosis in localized prostate cancer and inhibits PC3 cellular proliferation in vitro. Clin Cancer Res, 10, 615-25 (2004)
98. Berndt, T., T. A. Craig, A. E. Bowe, J. Vassiliadis, D. Reczek, R. Finnegan, S. M. Jan De Beur, S. C. Schiavi & R. Kumar: Secreted frizzled-related protein 4 is a potent tumor-derived phosphaturic agent. J Clin Invest, 112, 785-94 (2003)
99. Cebrat, M., L. Strzadala & P. Kisielow: Wnt inhibitory factor-1: a candidate for a new player in tumorigenesis of intestinal epithelial cells. Cancer Lett, 206, 107-13 (2004)
100. Tian, E., F. Zhan, R. Walker, E. Rasmussen, Y. Ma, B. Barlogie & J. D. Shaughnessy, Jr.: The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med, 349, 2483-94 (2003)
101. Wirths, O., A. Waha, S. Weggen, P. Schirmacher, T. Kuhne, C. G. Goodyer, S. Albrecht, D. Von Schweinitz & T. Pietsch: Overexpression of human Dickkopf-1, an antagonist of wingless/WNT signaling, in human hepatoblastomas and Wilms' tumors. Lab Invest, 83, 429-34 (2003)
102. Novak, A., S. C. Hsu, C. Leung-Hagesteijn, G. Radeva, J. Papkoff, R. Montesano, C. Roskelley, R. Grosschedl & S. Dedhar: Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways. Proc Natl Acad Sci U S A, 95, 4374-9 (1998)
103. Playford, M. P., D. Bicknell, W. F. Bodmer & V. M. Macaulay: Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of beta-catenin. Proc Natl Acad Sci U S A, 97, 12103-8 (2000)
104. Desbois-Mouthon, C., A. Cadoret, M. J. Blivet-Van Eggelpoel, F. Bertrand, G. Cherqui, C. Perret & J. Capeau: Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene, 20, 252-9 (2001)
105. Morali, O. G., V. Delmas, R. Moore, C. Jeanney, J. P. Thiery & L. Larue: IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene, 20, 4942-50 (2001)
106. Danilkovitch-Miagkova, A., A. Miagkov, A. Skeel, N. Nakaigawa, B. Zbar & E. J. Leonard: Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol Cell Biol, 21, 5857-68 (2001)
107. Graham, N. A. & A. R. Asthagiri: Epidermal growth factor-mediated T-cell factor/lymphoid enhancer factor transcriptional activity is essential but not sufficient for cell cycle progression in nontransformed mammary epithelial cells. J Biol Chem, 279, 23517-24 (2004)
108. Dann, C. E., J. C. Hsieh, A. Rattner, D. Sharma, J. Nathans & D. J. Leahy: Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature, 412, 86-90 (2001)
109. Bafico, A., A. Gazit, T. Pramila, P. W. Finch, A. Yaniv & S. A. Aaronson: Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem, 274, 16180-7 (1999)
110. Rodriguez, J., P. Esteve, C. Weinl, J. M. Ruiz, Y. Fermin, F. Trousse, A. Dwivedy, C. Holt & P. Bovolenta: SFRP1 regulates the growth of retinal ganglion cell axons through the Fz2 receptor. NatNeurosci, 8, 1301-9 (2005)
111. Lisovsky, M., K. Itoh & S. Y. Sokol: Frizzled receptors activate a novel JNK-dependent pathway that may lead to apoptosis. Curr Biol, 12, 53-8 (2002)
112. van den Brink, G. R., S. A. Bleuming, J. C. Hardwick, B. L. Schepman, G. J. Offerhaus, J. J. Keller, C. Nielsen, W. Gaffield, S. J. van Deventer, D. J. Roberts & M. P. Peppelenbosch: Indian Hedgehog is an antagonist of Wnt signaling in colonic epithelial cell differentiation. Nat Genet, 36, 277-82 (2004)
113. Kuhnert, F., C. R. Davis, H. T. Wang, P. Chu, M. Lee, J. Yuan, R. Nusse & C. J. Kuo: Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1. Proc Natl Acad Sci U S A, 101, 266-71 (2004)